Schedule I - Additional Information of Parent Company

12 Months Ended

Dec. 31, 2021

Condensed Financial Information Of Parent Company Only Disclosure [Abstract]

Schedule I - Additional Information of Parent Company

SCHEDULE I—ADDITIONAL INFORMATION OF THE PARENT COMPANY

ATRENEW INC.

CONDENSED BALANCE SHEETS

(Amounts in thousands, except for share, per share data or otherwise noted)

	Year ended December 31,
	2020			2021			2021
	RMB			RMB			US$
ASSETS
Current assets:
Cash and cash equivalents		76,865			45,520			7,143
Amounts due from related parties, net	—				22,315			3,502
Prepayments and other receivables, net		3,500			47,524			7,458
Total current assets		80,365			115,359			18,103
Non-current assets:
Long-term investments	—				23,694			3,718
Investments in subsidiaries’ and VIE’s subsidiaries		3,654,880			6,297,373			988,195
Other non-current assets		—			16,670			2,616
Total Non-current assets		3,654,880			6,337,737			994,529
Total ASSETS		3,735,245			6,453,096			1,012,632
LIABILITIES
Current liabilities:
Short-term borrowings		29,906			30,300			4,755
Accrued expenses and other current liabilities		4,500			2,337			367
Total current liabilities		34,406			32,637			5,122
Non-current liabilities:
Long-term borrowings		32,624			—		—
Total non-current liabilities		32,624			—		—
Total LIABILITIES		67,030			32,637			5,122
CONVERTIBLE REDEEMABLE PREFERRED SHARES (total redemption value of, RMB10,886,220 and nil as of December 31, 2020 and 2021, respectively)		8,879,894			—		—
SHAREHOLDERS’ EQUITY (DEFICIT)
Ordinary shares (US$0.001 par value,  192,499,052    shares authorized, 18,782,620 issued and outstanding as    of December 31, 2020)		11			—		—
Class A Ordinary shares (US$0.001 par value, 941,472,561 shares authorized, 100,854,060 share issued and 92,416,377  outstanding as of December 31, 2021)		—			609			96
Class B Ordinary shares (US$0.001 par value, 47,240,103 shares authorized, 47,240,103 share issued and outstanding as of December 31, 2021)		—			305			48
Class C Ordinary shares (US$0.001 par value, 11,287,336 shares authorized, 11,287,336 share issued and outstanding as of December 31, 2021)		—			7			1
Additional paid-in capital		—			12,954,163			2,032,791
Accumulated deficit		(5,213,773	)		(6,538,947	)		(1,026,103	)
Accumulated other comprehensive income		2,083			4,322			677
TOTAL SHAREHOLDERS’ EQUITY (DEFICIT)		(5,211,679	)		6,420,459			1,007,510
TOTAL LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY		3,735,245			6,453,096			1,012,632

SCHEDULE I—ADDITIONAL INFORMATION OF THE PARENT COMPANY

ATRENEW INC.

CONDENSED STATEMENTS OF COMPREHENSIVE LOSS

(Amounts in thousands, except for share, per share data or otherwise noted)

	Year ended December 31,
	2019			2020			2021			2021
	RMB			RMB			RMB			US$
Net revenues		—			—		—			—
Expenses and income (loss)
Selling and marketing expenses	—			—				(28	)		(4	)
General and administrative expenses		—			(1,000	)		(7,228	)		(1,134	)
Interest income		1,929			6			82			13
Interest expenses	—			—				(4,238	)		(665	)
Other income(loss), net		3,971			(19,844	)		(43,287	)		(6,793	)
Equity in losses of subsidiaries, VIE and VIE’s subsidiaries		(710,788	)		(449,780	)		(761,848	)		(119,552	)
Net loss attributable to the Company		(704,888	)		(470,618	)		(816,547	)		(128,135	)
Accretion of convertible redeemable preferred shares		(877,999	)		(1,304,498	)		(508,627	)		(79,815	)
Net loss available to ordinary shareholders		(1,582,887	)		(1,775,116	)		(1,325,174	)		(207,950	)

SCHEDULE I—ADDITIONAL INFORMATION OF THE PARENT COMPANY

ATRENEW INC.

CONDENSED STATEMENTS OF CASH FLOWS

(Amounts in thousands, except for share, per share data or otherwise noted)

	Year ended December 31,
	2019			2020			2021			2021
	RMB			RMB			RMB			USD
Cash used in operating activities		—			—			(4,295	)		(674	)
Cash flows from investing activities:
Purchase of long-term investments	—			—				(32,427	)		(5,089	)
Investments in subsidiaries’ and VIE’s subsidiaries		(584,758	)		(500,551	)		(2,589,491	)		(406,348	)
Cash used in investing activities		(584,758	)		(500,551	)		(2,621,918	)		(411,437	)
Cash flows from financing activities:
Proceeds from long-term borrowings		—			65,200		—			—
Repayment for short-term borrowings		—			(2,719	)		(32,230	)		(5,058	)
Proceeds from issuance of convertible redeemable preferred shares		469,636			512,715			1,138,232			178,615
Proceeds from IPO, net of issuance cost of RMB46,931		—			—			1,488,866			233,635
Cash provided by financing activities		469,636			575,196			2,594,868			407,192
Net increase (decrease) in cash, cash equivalents		(115,122	)		74,645			(31,345	)		(4,919	)
Cash, cash equivalent at the beginning of the year		117,342			2,220			76,865			12,062
Cash, cash equivalent at the end of the year		2,220			76,865			45,520			7,143
Supplemental cash flow disclosures of continuing operations:
Interest expenses paid		—			—			(4,238	)		(665	)
Supplemental disclosure of non-cash investing and financing activities:
Issuance of convertible redeemable preferred shares in    connection with Paipai acquisition from JD (Note 3),    accounted for as deemed contribution to the subsidiaries,    VIE and VIE’ subsidiaries		3,242,245			—			—			—
Exercise of warrant		—			—			10,345			1,623

SCHEDULE I

NOTES TO CONDENSED FINANCIAL INFORMATION OF PARENT COMPANY

1. Schedule I has been provided pursuant to the requirements of Rule 12-04(a) and 5-04(c) of Regulation S-X, which require condensed financial information as to the financial position, changes in financial position and results of operations of a parent company as of the same date and for the same period for which audited consolidated financial statements have been presented when the restricted net assets of consolidated subsidiaries exceed 25 percent of consolidated net assets as of the end of the most recently completed fiscal year.

2. The condensed financial information has been prepared using the same accounting policies as set out in the consolidated financial statements except that the equity method has been used to account for investments in its subsidiaries and VIE. For the parent company, the Company records its investments in subsidiaries and VIE under the equity method of accounting as prescribed in ASC 323, Investments—Equity Method and Joint Ventures. Such investments are presented on the Condensed Balance Sheet as “Investments in subsidiaries and VIE” or and the subsidiaries and VIE’ profit or loss as “Loss from equity in earnings of subsidiaries and VIE” on the Condensed Statements of Comprehensive Income (loss). Ordinarily under the equity method, an investor in an equity method investee would cease to recognize its share of the losses of an investee once the carrying value of the investment has been reduced to nil absent an undertaking by the investor to provide continuing support and fund losses. For the purpose of this Schedule I, the parent company has continued to reflect its share, based on its proportionate interest, of the losses of subsidiaries and VIE regardless of the carrying value of the investment even though the parent company is not obligated to provide continuing support or fund losses.

3. Certain information and footnote disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted. The footnote disclosures provide certain supplemental information relating to the operations of the Company and, as such, these statements should be read in conjunction with the notes to the accompanying consolidated financial statements.

4. Besides the short-term borrowings existed as of the year ended December 31, 2021, there were no other material contingencies, significant provisions of long-term obligations, guarantees of the Company for the years ended December 31, 2019, 2020 and 2021.